Latkin Jed 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Feb 11, 2019
Insider Transaction Report
Form 4
Latkin Jed
Interim COO
Transactions
- Award
Stock Option
2019-02-07+1,000,000→ 2,065,000 totalExp: 2029-02-07→ Common Stock (1,000,000 underlying)
Footnotes (1)
- [F1]333,334 options with a strike price of $0.15 will be exercisable on or after 2/7/2019, so long as the closing market price of the underlying common stock equals or exceeds $0.50 per share; 333,333 options with a strike price of $0.30 will be exercisable on or after 12/31/2019, so long as the closing market price of the underlying common stock equals or exceeds $0.70 per share; and 333,333 options with a strike price of $0.50 will be exercisable on or after 12/31/2020, so long as the closing market price of the underlying common stock equals or exceeds $1.00 per share.